Redeye updates its estimates and valuation following Coala Life’s recent rights issue, securing cSEK55m in growth capital and resulting in a 75% dilution for non-participating shareholders. CEO
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
© Modular Finance, source